With a new cloud-based tool dubbed HIVE, the US Food and Drug Administration is readying itself for the onslaught of next-generation sequencing data that will soon be included in many regulatory submissions, the FDA Voice blog says.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genetic mechanism through which some cancers evade the immune system, and more.
The Wall Street Journal reports that Walgreens didn't fully vet Theranos before entering partnership.
Jeremy Berg is to be the next editor in chief of Science magazine.
Regeneron Pharmaceuticals is to be the new sponsor of the prestigious high school Science Talent Search competition, according to the New York Times.